Bright Green Corp
NASDAQ:BGXX
Bright Green Corp
NASDAQ:BGXX
Price:
0.038
USD
-2.56%
Market Closed
Market Cap:
$60k
Relative Value
There is not enough data to reliably calculate the relative value of BGXX.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BGXX
Relative Value
Base Case
Not Available
Multiples Across Competitors
BGXX Competitors Multiples
Bright Green Corp Competitors
Bright Green Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Bright Green Corp
NASDAQ:BGXX
|
60k USD | 0 | -0 | -0.2 | -0.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
948.8B USD | 16 | 51.5 | 34.6 | 37.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563B USD | 6 | 21 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.3B CHF | 4.6 | 30.1 | 12.7 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
211.8B GBP | 5.1 | 31.3 | 15 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.1B USD | 4.5 | 15.1 | 10.7 | 12.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
223B CHF | 5.1 | 19.7 | 12.4 | 16 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.3 | 12.9 | 9 | 10.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD | 2.3 | 14.9 | 7.6 | 10.3 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
